Juvenile Idiopathic Arthritis: Features of DMARD and SSARD Drugs

Juvenile Idiopathic Arthritis: Features of DMARD and SSARD Drugs

Topic Overview

Children who have juvenile idiopathic arthritis (JIA) are first treated with nonsteroidal anti-inflammatory drugs ( NSAIDs ) that often provide relief and reduce inflammation. NSAIDs are considered the first-line treatment for JIA. Second-line drug therapy—known interchangeably as disease-modifying antirheumatic drugs (DMARDs) and as slow-acting antirheumatic drugs (SAARDs)—for JIA may be recommended when a child continues to have joint pain, swelling, or both despite rest, exercise, use of NSAIDs, and physical therapy.

DMARDs/SAARDs include azathioprine, cyclosporine, etanercept, methotrexate, and sulfasalazine.

DMARDs/SAARDs have a lot in common.

  • They are slow to take effect. It may take 8 to 24 weeks for the drug to show a benefit.
  • They have a small risk of serious side effects (on blood cells, eyes, kidney, or liver). Side effects can be detected with close monitoring and are reversible if the drug is stopped.
  • They have a moderate risk of side effects that may be uncomfortable but are not serious (nausea, skin rash, mouth sores, diarrhea, hair thinning).
  • While these medicines offer effective treatment for many children, they are not a reasonable treatment option for others. Side effects or ineffectiveness, or both, are common reasons that children are withdrawn from DMARD/SAARD treatment.
  • NSAIDs are often used together with one of these medicines.

Although these medicines are often called "disease-modifying," it has been hard to prove that they truly prevent long-term joint damage. But they often relieve pain and swelling.

Related Information

Credits

ByHealthwise Staff
Primary Medical ReviewerSusan C. Kim, MD - Pediatrics
Specialist Medical ReviewerJohn Pope, MD - Pediatrics
Last RevisedJune 5, 2012

Last Revised: June 5, 2012

This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use . How this information was developed to help you make better health decisions.

© 1995-2013 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.